ABBVIE INC. vs. Johnson & Johnson
Johnson & Johnson (JNJ) comes out ahead, leading on 9 of 11 compared factors.
Size & Scale
| ABBV | JNJ | |
|---|---|---|
| Market Cap | $466.55 billion | $650.65 billion |
| Revenue (TTM) | $64.39 billion | $97.93 billion |
| Net Income (TTM) | $6.32 billion | $21.04 billion |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| ABBV | JNJ | |
|---|---|---|
| P/E Ratio | 74.71 | 31.32 |
| Price / Book | -79.24 | 7.66 |
| Price / Sales | 7.25 | 6.64 |
JNJ leads on 2 of 3 valuation factors.
Profitability
| ABBV | JNJ | |
|---|---|---|
| Net Margin | 9.81% | 21.48% |
| Return on Equity | -107.29% | 24.76% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| ABBV | JNJ | |
|---|---|---|
| Dividend Yield | 2.62% | 1.99% |
| Payout Ratio | 195.48 | 62.18 |
ABBV and JNJ split the dividend factors evenly.
Risk & Sentiment
| ABBV | JNJ | |
|---|---|---|
| Short Interest | 0.85% | 0.67% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, JNJ overview, JNJ financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.